Court Rules
All enforcement actions
CoalitionLow RiskMultistate

Attorney General Tong Joins Bipartisan Effort to Curb Sales of Illegal Vaping Products

Bipartisan Coalition of 25 State Attorneys General and City of New YorkApril 28, 2026Connecticut Attorney General

Summary

On April 28, 2026, Connecticut Attorney General William Tong joined a bipartisan coalition of 24 other state attorneys general and New York City in sending letters to major credit card companies and payment processors urging them to block transactions facilitating illegal vaping product sales. The coalition highlighted that most vapor products lack required FDA authorization and many online sellers violate the federal Prevent All Cigarette Trafficking (PACT) Act, including failing to implement youth access safeguards. The coalition requested a meeting to discuss prohibiting noncompliant merchants from using payment networks, building on existing state enforcement actions against illegal vape sellers.

Contract Impact

In-house legal teams at payment processors should review merchant agreements to include requirements for FDA authorization of e-cigarette products, compliance with PACT Act obligations including age verification and registration, and prohibitions on selling illegal vapes. Vape merchants should review payment processor agreements to ensure compliance with federal and state laws to avoid termination. All parties should verify that contracts include rights to audit merchant compliance and terminate for cause related to illegal sales, with specific clauses addressing youth access and prohibited product sales.

Contract Search Terms

FDA e-cigarette authorizationPACT Act complianceage verification requirementsyouth access safeguardsmerchant registrationprohibited product clausesinterstate commerce complianceillegal vape sales

Laws Cited

Prevent All Cigarette Trafficking (PACT) ActFederal Food, Drug, and Cosmetic Act

Violation Types

Entity Details

Entity

Bipartisan Coalition of 25 State Attorneys General and City of New York

Industry

Other

Multistate Coalition

Official Sources

Source Evidence

Title
"Attorney General Tong Joins Bipartisan Effort to Curb Sales of Illegal Vaping Products"
Event Date
"04/28/2026"
Jurisdiction
"Office of the Attorney General William Tong"
Event Type
"joined a bipartisan coalition of 24 other attorneys general and the City of New York"
Entity Name
"bipartisan coalition of 24 other attorneys general and the City of New York"
Laws Cited
"Federal law requires that all e-cigarette products receive authorization from the U.S. Food and Drug Administration (FDA) before they can be legally marketed or sold in the United States."

Related Enforcement Actions

CT

U.S. Department of the Interior

Connecticut Attorney General William Tong joined other state attorneys general in suing the federal government over deals that canceled offshore wind leases in exchange for payments to Bluepoint Wind and Invenergy. The states allege the deals unlawfully used taxpayer funds and failed to follow required procedures, and ask the courts to invalidate the deals and block their implementation.

CT

Glenmark, Lannett, Bausch, Apotex, Heritage, and Emcure

Connecticut and a coalition of 47 other states and territories announced preliminary court approval of a plan to distribute funds from settlements with generic drug manufacturers accused of conspiring to inflate drug prices. The release does not give the date of the court’s preliminary approval, so the event date reflects the press release date.

CT

Warner Bros./Paramount

Connecticut Attorney General William Tong issued a statement regarding a consent decree secured with Warner Bros./Paramount to protect editorial independence of CNN and CBS News. The consent decree establishes an editorial board structure, though the AG expressed disappointment that full divestiture was not achieved.

CT

Credit Acceptance Corporation

$694.0M

Connecticut Attorney General William Tong joined 40 other state attorneys general in a settlement with Credit Acceptance Corporation (CAC), one of the nation's largest subprime auto lenders, resolving allegations that CAC originated loans it knew or should have known consumers could not afford and encouraged or failed to prevent dealers from 'packing' CAC loans with unwanted Vehicle Service Contract (VSC) and GAP products. The settlement, announced September 17, 2026 and effective November 2, 2026, directs $694 million in cash restitution and debt relief to consumers, plus an additional $15 million to the states, and imposes injunctive lending reforms. Note: this is a consumer-protection/lending enforcement action rather than a data privacy matter; the violation categories are best-fit mappings to the available taxonomy.

CT

N/A - General advisory to Connecticut businesses and consumers (no specific entity)

Connecticut Attorney General William Tong issued an advisory that newly enacted privacy laws take effect October 1, 2026, including Public Act 26-64 (SB4), which amends the Connecticut Data Privacy Act, and Public Act 26-15 (SB5), which established the Connecticut Artificial Intelligence Responsibility and Transparency Act (CART Act). The new laws regulate surveillance pricing, facial recognition technology, genetic data collected by direct-to-consumer testing companies, a ban on the sale of precise geolocation data, a data broker registry, AI use in employment decisions, and chatbots offered to children. No enforcement action was taken; this is prospective guidance alerting consumers and businesses to new rights and compliance requirements.

CT

Abbott Laboratories

$384.2M

Connecticut joined 39 other states and the federal government in a $384 million False Claims Act settlement with Abbott Laboratories over allegations that the company failed to manufacture powder infant formula and nutritional therapy products in compliance with federal and state requirements at its Sturgis, Michigan, and Casa Grande, Arizona facilities. Abbott allegedly manufactured formula in conditions that risked microorganism contamination and failed to disclose contamination test results to the FDA during 2019 and 2022 inspections. The settlement resolves claims that Abbott caused false claims to be submitted to the WIC program and state Medicaid programs between January 1, 2018, and December 31, 2022.